Skip to main content
. 2019 Mar 2;39:7. doi: 10.1186/s40880-019-0354-z

Fig. 3.

Fig. 3

Kaplan-Meier curves of the progression-free survival (PFS) and overall survival (OS) for mutant-EGFR NSCLC patients with aberrations in PTEN and MET genes. PFS (a) and OS (b) were analyzed in the 169 EGFR-mutant NSCLC patients, according to PTEN copy number alterations. In the subgroups of EGFR-mutant NSCLC patients with MET FISH status, PFS (c) and OS (d) were analyzed. The survival rates were compared using the log-rank test